vanadates has been researched along with Hyperhomocysteinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goel, RK; Ivanov, S; Kumar, S; Lagunin, A | 1 |
| Shah, DI; Singh, M | 1 |
2 other study(ies) available for vanadates and Hyperhomocysteinemia
| Article | Year |
|---|---|
Attenuation of hyperhomocysteinemia induced vascular dementia by sodium orthovanadate perhaps via PTP1B: Pertinent downstream outcomes.
Topics: Alzheimer Disease; Animals; Brain; Dementia, Vascular; Disease Models, Animal; Hyperhomocysteinemia; Male; Maze Learning; Mice; Oxidative Stress; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Vanadates | 2019 |
Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction.
Topics: Animals; Aorta, Thoracic; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Hyperhomocysteinemia; Male; Methionine; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitrites; Potassium Channels; Protein Tyrosine Phosphatases; Pyrones; Rats; Rats, Sprague-Dawley; Streptozocin; Thiobarbituric Acid Reactive Substances; Vanadates; Vasodilation | 2006 |